Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 23, 2023 - Issue 12
Submit an article Journal homepage
1,739
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Pharmacokinetic and pharmacodynamic similarity of biosimilar natalizumab (PB006) to its reference medicine: a randomized controlled trial

Hendrik Wesselsa Polpharma Biologics S.A, Gdansk, PolandView further author information
,
Oliver von Richterb Hexal AG (A Sandoz company), Holzkirchen, GermanyView further author information
,
Maria Velinovac Early Development Services, ICON, Groningen, The NetherlandsView further author information
,
Josef Höflerd Staburo GmbH, Munich, GermanyView further author information
,
Paul Chamberlaine bioLOGICA Consulting, Arthez d’Asson, FranceView further author information
,
Arno Krommingaf Kromminga Consulting, Hamburg, GermanyView further author information
,
Dirk Lehnickg Faculty of Health Sciences and Medicine, University of Lucerne, Lucerne, SwitzerlandView further author information
&
Karsten Rotha Polpharma Biologics S.A, Gdansk, PolandCorrespondence[email protected]
View further author information
 show all
Pages 1287-1297 | Received 10 Nov 2023, Accepted 29 Nov 2023, Published online: 05 Dec 2023

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.